Thanks to PAN, we have the rare opportunity to ask direct questions of the FDA in a Webinar. Questions on Duodopa, sham surgery, pay for delay...now is the time to be voice our concerns and to show appreciation for what they do well.

You must register and submit your question in advance. I have a feeling they will choose questions that are most commonly asked or submitted. I am going to ask about Duodopa specifically why it it is still awaiting approval 11 years after its application?

The Food and Drug Administration:
How it Impacts the Parkinson’s Community

Mark your calendar for December 12th at 3-4:30 EST

See you there!

Laura